• PROMOTE YOUR VENTURE
    • Startup listings
    • IP & Tech listings
  • GET HELP
    • Search questions
    • Post projects
    • Search expert directory
  • RESOURCES
    • Document Center
    • Search for patents
    • Expert articles / posts
  • NEWS & EVENTS
    • Tech & IP News
  • My Account
  • Sign in
  • FOR PROFESSIONALS

Patents

68,025 found
SEE ALL IP TYPES
PATENTFIELD SEARCH
UPLOAD IP
Pending

Hyaluronan

Hyaluronan (also called hyaluronic acid or hyaluronate or HA) is an anionic, nonsulfated glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues. It is unique amo...

Pending

Pollen allergy

Nasal allergy to pollen is called pollinosis, and allergy specifically to grass pollen is called hay fever. Generally, pollens that cause allergies are those of anemophilous plants (pollen is dispe...

Pending

Artifact removal in medical...

Artifact removal in medical images

Pending

Drug-induced nausea

Drug-induced nausea

Granted

LIGHT

Tumor necrosis factor ligand superfamily member 14 is a protein that in humans is encoded by the TNFSF14 gene.[1][2] TNFSF14 has also been designated as CD258,[citation needed] as well as LIGHT.[3]...

Pending

Drug-induced nausea

Drug-induced nausea

Pending

Production of methane from CO2

Naturally occurring methane is mainly produced by the process of methanogenesis. This multistep process is used by microorganisms as an energy source. The net reaction is: CO2 + 8 H+ + 8 e− → CH...

Granted

Lubricant

A lubricant is a substance introduced to reduce friction between surfaces in mutual contact, which ultimately reduces the heat generated when the surfaces move. It may also have the function of tra...

Pending

Detecting organisms using s...

Detecting organisms using stochastic confinement

Granted

Liver X receptor agonists

LXR agonists are effective for treatment of murine models of atherosclerosis, diabetes, anti-inflammation, and Alzheimer's disease. Treatment with LXR agonists (hypocholamide, T0901317, GW3965, or ...

Pending

Assaying blood clotting

Coagulation (clotting) is the process by which blood changes from a liquid to a gel. It potentially results in hemostasis, the cessation of blood loss from a damaged vessel, followed by repair. The...

Pending

Electrolytic production of ...

The conversion of alumina to aluminum metal is achieved by the Hall-Héroult process. In this energy-intensive process, a solution of alumina in a molten (950 and 980 °C (1,740 and 1,800 °F)) mixtur...

Pending

Reducing cell death

Cell death is the event of a biological cell ceasing to carry out its functions. This may be the result of the natural process of old cells dying and being replaced by new ones, or may result from ...

Granted

NKT cell

Natural killer T (NKT) cells are a heterogeneous group of T cells that share properties of both T cells and natural killer (NK) cells. Many of these cells recognize the non-polymorphic CD1d molecul...

Granted

Hypothermia

Hypothermia (from Greek ὑποθερμία) is a condition in which the body's core temperature drops below that required for normal metabolism and body functions. This is generally considered to be less th...

Granted

Plants modified with mini-c...

In 2006, scientists demonstrated the successful use of telomere truncation in maize plants to produce minichromosomes that could be utilized as a platform for inserting genes into the plant genome[...

Pending

Engineered herpes simplex v...

Engineered herpes simplex virus

Pending

APOA1

Apolipoprotein A-I is a protein that in humans is encoded by the APOA1 gene.[1][2] It has a specific role in lipid metabolism. Recent report suggest that APOA1 mRNA is regulated by endogenously exp...

Pending

Myelination disorders

A demyelinating disease is any disease of the nervous system in which the myelin sheath of neurons is damaged.[1] This damage impairs the conduction of signals in the affected nerves. In turn, the ...

Granted

Optical fractionation

Optical fractionation

  • First
  • Prev
  • …
  • 1761
  • 1762
  • 1763
  • 1764
  • 1765
  • 1766
  • 1767
  • 1768
  • 1769
  • …
  • Next
  • Last
Your one-stop shop for innovation and intellectual property Join us today

About us

IP Nexus is an IP commercialisation company that builds successful startup companies by collaborating with inventors, universities and research institutes to identify high-potential inventions at an early stage and provide the commercial direction, fundraising expertise and management talent necessary to build outstanding companies. IP Nexus has particular focus and expertise in Asia.

Disclaimer

IP Nexus, including the Ask an Expert and Services Marketplace, is an interactive online service that makes it faster and easier for businesses to find and hire legal help solely based on their search preferences. We are not a law firm, do not provide any legal services, legal advice or lawyer referral services and do not provide or participate in any legal representation.

Content

  • PRICING
  • FREQUENTLY ASKED QUESTIONS
  • IP PROTECTION
  • IP TYPES
  • IP CLAIMS
  • OUR TEAM
  • STARTUPS
  • CONTACT US
  • BRAND ASSETS
  • TERM OF USE
  • PRIVACY POLICY
  • SEARCH PATENTS ON PATENTFIELD

Newsletter

Subscribe

Languages

© 2026 IP Nexus. All Rights Reserved.

Report content

      Contact form